Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-01 Sale |
2023-05-03 5:34 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | RASTETTER WILLIAM H Director |
4,300 | $101.43 | $436,135 | 42,785 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 5:28 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
11,397 | $103.89 | $1,184,049 | 16,169 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-27 4:37 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
100 | $103.82 | $10,382 | 27,561 (Direct) |
View |
| 2023-04-24 Sale |
2023-04-26 9:22 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
14,400 | $103.48 | $1,490,059 | 26,644 (Direct) |
View |
| 2023-04-19 Sale |
2023-04-21 6:58 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | RASTETTER WILLIAM H Director |
6,937 | $105.03 | $728,605 | 65,475 (Direct) |
View |
| 2023-02-23 Purchase |
2023-02-24 06:15 am |
Voyager Therapeutics Inc. | VYGR | NEUROCRINE BIOSCIENCES INC 10% Owner |
4,395,588 | $8.88 | $39,032,821 | 8,575,316 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:56 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
17,079 | $102.76 | $1,755,121 | 27,424 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:40 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
16,525 | $102.74 | $1,697,707 | 41,015 (Direct) |
View |
| 2023-02-07 Sale |
2023-02-08 7:38 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
4,508 | $102.3 | $461,166 | 6,525 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:35 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Integration Officer |
15,318 | $102.64 | $1,572,197 | 42,337 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:32 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
16,275 | $102.71 | $1,671,637 | 44,973 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:28 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
29,044 | $102.9 | $2,988,758 | 491,365 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:25 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
17,004 | $102.79 | $1,747,920 | 128,096 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:22 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Boyer David W. Chief Corp. Affairs Officer |
25,238 | $102.49 | $2,586,741 | 4,755 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:18 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
19,650 | $102.7 | $2,018,105 | 34,381 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:16 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
28,588 | $102.61 | $2,933,470 | 25,213 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:28 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
1,457 | $109.99 | $160,254 | 26,171 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:26 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
126 | $108.48 | $13,668 | 2,477 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:24 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Integration Officer |
1,666 | $110.02 | $183,290 | 28,582 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:21 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
1,250 | $109.97 | $137,464 | 30,357 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:19 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,707 | $110.08 | $297,997 | 465,278 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:15 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
1,541 | $109.98 | $169,486 | 112,820 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:07 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
916 | $108.48 | $99,368 | 15,926 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:04 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Boyer David W. Chief Corp. Affairs Officer |
1,104 | $109.92 | $121,349 | 3,911 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:00 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
1,207 | $109.95 | $132,710 | 16,729 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 4:53 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,283 | $109.98 | $141,108 | 21,357 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-01 Exercise |
2023-05-03 5:34 pm |
N/A 2023-05-23 |
NEUROCRINE BIOSCIENCES INC | NBIX | RASTETTER WILLIAM H Director |
7,625 | $12.71 | 42,785 (Direct) |
View |
| 2023-04-19 Exercise |
2023-04-21 6:58 pm |
N/A 2023-05-23 |
NEUROCRINE BIOSCIENCES INC | NBIX | RASTETTER WILLIAM H Director |
12,375 | $12.71 | 65,475 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:32 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Delaet Ingrid Chief Regulatory Officer |
39,205 | $0 | 39,205 (Direct) |
View |
Ownership |
2023-02-15 7:30 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | Delaet Ingrid Chief Regulatory Officer |
0 | $0 | 42,550 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:15 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
60,985 | $0 | 60,985 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:14 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
78,409 | $0 | 78,409 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:13 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
60,114 | $0 | 60,114 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:11 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
155,162 | $0 | 155,162 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:10 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
74,053 | $0 | 74,053 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:08 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
43,561 | $0 | 43,561 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:07 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Boyer David W. Chief Corp. Affairs Officer |
52,272 | $0 | 52,272 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:06 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
60,114 | $0 | 60,114 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:04 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
74,053 | $0 | 74,053 (Direct) |
View |